141 related articles for article (PubMed ID: 38344717)
1. Clopidogrel for Proteinuria Reduction in Focal Segmental Glomerulosclerosis: Phase 2 Trial Design.
Daniel-Fischer L; Antlanger M; Cejka D; Eller K; Gauckler P; Odler B; Rudnicki M; Säemann MD; Schmidt A; Sunder-Plassmann G; Wiesholzer M; Windpessl M; Zitt E; Koenig F; Greenbaum LA; Kronbichler A; Aufricht C
Kidney Int Rep; 2024 Feb; 9(2):478-481. PubMed ID: 38344717
[No Abstract] [Full Text] [Related]
2. Computational drug repositioning of clopidogrel as a novel therapeutic option for focal segmental glomerulosclerosis.
Gebeshuber CA; Daniel-Fischer L; Regele H; Schachner H; Aufricht C; Kornauth C; Ley M; Alper SL; Herzog R; Kratochwill K; Perco P
Transl Res; 2023 Sep; 259():28-34. PubMed ID: 37059330
[TBL] [Abstract][Full Text] [Related]
3. Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Troost JP; Trachtman H; Spino C; Kaskel FJ; Friedman A; Moxey-Mims MM; Fine RN; Gassman JJ; Kopp JB; Walsh L; Wang R; Gipson DS
Am J Kidney Dis; 2021 Feb; 77(2):216-225. PubMed ID: 32791086
[TBL] [Abstract][Full Text] [Related]
4. Plasma microRNA-186 and proteinuria in focal segmental glomerulosclerosis.
Zhang C; Zhang W; Chen HM; Liu C; Wu J; Shi S; Liu ZH
Am J Kidney Dis; 2015 Feb; 65(2):223-32. PubMed ID: 25218681
[TBL] [Abstract][Full Text] [Related]
5. Secondary Focal Segmental Glomerulosclerosis: From Podocyte Injury to Glomerulosclerosis.
Kim JS; Han BG; Choi SO; Cha SK
Biomed Res Int; 2016; 2016():1630365. PubMed ID: 27088082
[TBL] [Abstract][Full Text] [Related]
6. Assessing the Impact of Losmapimod on Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis.
Gipson DS; Hladunewich MA; Lafayette R; Sedor JR; Rovin BH; Barbour SJ; McMahon A; Jennette JC; Nachman PH; Willette RN; Paglione M; Gao F; Ross Terres JA; Vallow S; Holland MC; Thorneloe KS; Sprecher DL
Kidney Int Rep; 2020 Aug; 5(8):1228-1239. PubMed ID: 32775822
[TBL] [Abstract][Full Text] [Related]
7. High-Dose Rituximab Ineffective for Focal Segmental Glomerulosclerosis: A Long-Term Observation Study.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Barreca A; Fenoglio R; Baldovino S; Menegatti E
Am J Nephrol; 2017; 46(2):108-113. PubMed ID: 28700988
[TBL] [Abstract][Full Text] [Related]
8. A case of recurrent focal segmental glomerulosclerosis (FSGS) involving massive proteinuria (>50 g/day) immediately after renal transplantation.
Okamoto M; Koshino K; Sakai K; Nobori S; Matsuyama M; Ushigome H; Okajima H; Masuzawa N; Yoshimura N
Clin Transplant; 2011 Jul; 25 Suppl 23():53-8. PubMed ID: 21623916
[TBL] [Abstract][Full Text] [Related]
9. CUBN gene mutations may cause focal segmental glomerulosclerosis (FSGS) in children.
Yang J; Xu Y; Deng L; Zhou L; Qiu L; Zhang Y; Zhou J
BMC Nephrol; 2022 Jan; 23(1):15. PubMed ID: 34979989
[TBL] [Abstract][Full Text] [Related]
10. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
11. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease.
Thadhani R; Pascual M; Nickeleit V; Tolkoff-Rubin N; Colvin R
Lancet; 1996 Jan; 347(8996):231-3. PubMed ID: 8551883
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis.
Usui T; Morito N; Shawki HH; Sato Y; Tsukaguchi H; Hamada M; Jeon H; Yadav MK; Kuno A; Tsunakawa Y; Okada R; Ojima T; Kanai M; Asano K; Imamura Y; Koshida R; Yoh K; Usui J; Yokoi H; Kasahara M; Yoshimura A; Muratani M; Kudo T; Oishi H; Yamagata K; Takahashi S
Kidney Int; 2020 Aug; 98(2):391-403. PubMed ID: 32622525
[TBL] [Abstract][Full Text] [Related]
13. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Naito S; Kawashima N; Ishii D; Fujita T; Iwamura M; Takeuchi Y
Clin Exp Nephrol; 2022 Nov; 26(11):1078-1085. PubMed ID: 35804208
[TBL] [Abstract][Full Text] [Related]
14. Rapid and persistent reduction of proteinuria following plasma exchange in a case of steroid-resistant focal segmental glomerulosclerosis.
Ishii E; Ando Y; Tamba K; Masunaga Y; Kusano E; Asano Y
Ther Apher; 2002 Apr; 6(2):174-7. PubMed ID: 11982961
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.
Wen Y; Shah S; Campbell KN
Front Med (Lausanne); 2018; 5():98. PubMed ID: 29713631
[TBL] [Abstract][Full Text] [Related]
16. Pediatric focal segmental glomerulosclerosis: favorable transplantation outcome with plasma exchange.
Fadel FI; Bazaraa HM; Abdel Mawla MA; Salah DM
Ital J Pediatr; 2021 Dec; 47(1):236. PubMed ID: 34906202
[TBL] [Abstract][Full Text] [Related]
17. Collapsing Lesions and Focal Segmental Glomerulosclerosis in Pregnancy: A Report of 3 Cases.
Orozco Guillén OA; Velazquez Silva RI; Gonzalez BM; Becerra Gamba T; Gutiérrez Marín A; Paredes NR; Cardona Pérez JA; Soto Abraham V; Piccoli GB; Madero M
Am J Kidney Dis; 2019 Dec; 74(6):837-843. PubMed ID: 31378644
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria.
Abuzeineh M; Aala A; Alasfar S; Alachkar N
BMC Nephrol; 2020 Jul; 21(1):253. PubMed ID: 32615995
[TBL] [Abstract][Full Text] [Related]
19. Proteinuria after injection of human focal segmental glomerulosclerosis factor.
Sharma M; Sharma R; Reddy SR; McCarthy ET; Savin VJ
Transplantation; 2002 Feb; 73(3):366-72. PubMed ID: 11884932
[TBL] [Abstract][Full Text] [Related]
20. Effect of plasma fractions from patients with focal and segmental glomerulosclerosis on rat proteinuria.
Le Berre L; Godfrin Y; Lafond-Puyet L; Perretto S; Le Carrer D; Bouhours JF; Soulillou JP; Dantal J
Kidney Int; 2000 Dec; 58(6):2502-11. PubMed ID: 11115084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
